Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease

Molecular Psychiatry

Volumn 6, Issue 3, 2001, Pages 350-352

  Mossner R ^a   Henneberg, A ^b   Schmitt, A ^a   Syagailo, Y V ^a   Grassle M ^a   Hennig, T ^a   Simantov, R ^c   Gerlach, M ^a   Riederer, P ^a   Lesch, K P ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Hospital for Parkinson's Disease   (Germany)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Depression; Monoamine oxidase A; Parkinson's disease; Polymorphism; Promoter; Serotonin transporter

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; SEROTONIN TRANSPORTER;

ARTICLE; DEPRESSION; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SEROTONIN UPTAKE;

ALLELES; CARRIER PROTEINS; DEPRESSION; FEMALE; GENE EXPRESSION; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MONOAMINE OXIDASE; NERVE TISSUE PROTEINS; PARKINSON DISEASE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; VARIATION (GENETICS);

EID: 17744384689     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000849     Document Type: Article

References (22)

1. Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype
2. Depression and Parkinson's disease: A review
3. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease
4. Depression in Parkinson's disease
5. Aminergic systems in Alzheimer's disease and Parkinson's disease
6. Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease
7. Parkinson's disease: Distribution of Lewy bodies and monoamine neuron system
8. High and low affinity [3H]imipramine binding sites in control and parkinsonian brains
9. Parkinson's disease: Decreased density of 3H-imipramine and 3H-paroxetine binding sites in putamen
10. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region
11. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels
12. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity
13. Excess of high activity monoamine oxidase A gone promoter alleles in female patients with panic disorder
14. A functional polymorphism in the promoter of monoamine oxidase A gene and bipolar affective disorder
15. A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorders
16. Depression and anxiety in Parkinson's disease: Possible effect of genetic variation in the serotonin transporter
17. Association of a serotonin transporter gene promoter polymorphism with harm avoidance behaviour in an elderly population
18. Polymorphism within the promoter of the serotonin transporter gone and antidepressant efficacy of fluvoxamine
19. Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gone
20. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease